Clinical Trial Search

Primary: Caregivers' Comfort in Managing Shortness of Breath as Assessed by a Likert Scale at Pre-Intervention — 3.0 score on a scale

Primary: Endogenous Oxalate Synthesis Rate — 17 mg/day

Primary: Percentage of Participants Having Established SARS-CoV-2-specific T Cells After Receiving a modRNA Vaccine — 80.0; 87.5; 100.0; 46.7 percentage of participants

Primary: Number of Patients With Complete Response (CR) or Partial Response (PR) — 3; 3; 14; 23 Participants

Primary: Number of Participants With Serious Adverse Events and Non-Serious Adverse Events — 435; 1215 Participants

Primary: Prevention of Vomiting Measured by Vomiting Assessment (VA) — 22; 24; 54 Participants

Primary: Number of Premenopausal Women With Overweight/Obesity Who Initiated a COC vs. Continued NHC Use, Enrolled and Remained in This Study, and Completed Outcome Measures — 9…

Primary: Largest Change From Baseline on Clinical Pain Rating — 24.19; 30.48; 28.55; 26.38 score on a scale — p=.021

Primary: Qualitative Analysis of Focus Group Audio-recording Transcripts. Open Coding Using Content Analysis Framework Will be Utilized to Assess Positive Regard for the…

Primary: Chest X-ray Results on Day 3 After Pleurodesis — 5; 6; 5; 8 Participants — p=0.863

Primary: PaO2/FiO2 Ratio at ICU Admission (Time 0) and 24 Hours — 346.3; 337.9; 320.1; 307.3 ratio of PaO2/FiO2 — p=0.8541

Primary: Number of Participants With Dose-Limiting Toxicities — 0; 0; 0; 0 Participants

Primary: Change in SDQ Emotional Problems — 2.08; -4.49 units on a scale — p=0.38

Primary: Change in Pain — 1.64; 1.53; -2.12 score on a scale

Primary: Muscle Size Change — 47.76; 31.1; 52.4; 36.0 Muscle CSA (cm^2)